Zacks.com featured highlights include: Columbia Sportswear, Fossil Group, Alexion and Shoe Carnival source https://finance.yahoo.com/news/zacks-com-featured-highlights-columbia-151403845.html?.tsrc=rss

NEW YORK, NY / ACCESSWIRE / September 13, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the…… Read more “CARB, CAH & JE – Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action”

Georgia Power has picked another Atlanta-area CEO for its board of directors with the addition of Bakkt CEO Kelly L. Loeffler. Bakkt, a subsidiary of Intercontinental Exchange…… Read more “CEO of Atlanta startup joins Georgia Power board of directors”

NEW YORK, NY / ACCESSWIRE / September 13, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the…… Read more “Class Actions – NGHC, IFF & GVA – Bronstein, Gewirtz & Grossman, LLC”

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios… source https://finance.yahoo.com/news/does-national-general-holdings-corp-142738098.html?.tsrc=rss

NEW YORK, NY / ACCESSWIRE / September 13, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the…… Read more “L Brands, Inc. (LB), GTT Communications, Inc. (GTT) & Abiomed, Inc. (ABMD) – Class Action – Bronstein, Gewirtz & Grossman, LLC”

Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news. source https://finance.yahoo.com/m/3bedaa56-9641-3b48-9c71-f4c00eca9b15/walgreens-stock%3A-deutsche.html?.tsrc=rss

ANSYS (ANSS) announces acquisition of LS-DYNA simulation software provider, Livermore. The deal is expected to enhance ANSYS' automotive customer base. source https://finance.yahoo.com/news/ansys-acquire-livermore-boost-automotive-141002416.html?.tsrc=rss

Glaxo's (GSK) asthma medicine, Nucala gets FDA approval for use in pediatric patient population. source https://finance.yahoo.com/news/glaxos-asthma-drug-nucala-gets-140802506.html?.tsrc=rss

Adverum Biotechnologies (ADVM) announces data from one cohort of an early-stage study, evaluating its gene therapy candidate, ADVM-022, in patients with wet AMD. source https://finance.yahoo.com/news/adverum-reports-data-phase-wet-140602217.html?.tsrc=rss